High Protein Atkin's Complete (Lacto) VEgetaRian Diet (PACER) and Weight Loss
PACER
To Determine the Effect of PACER Diet (High Protein Atkin's Complete VEgetaRian Diet) in Obese Subjects
1 other identifier
interventional
104
1 country
1
Brief Summary
This study evaluates the effects "High Protein Atkin's Complete (lacto) VEgetaRian Diet (Acronym; 'PACER' diet) on weight, body composition and metabolic profiles in obese Asian Indians subjects living in north India.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Jan 2012
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 26, 2015
CompletedFirst Posted
Study publicly available on registry
September 29, 2015
CompletedSeptember 29, 2015
September 1, 2015
2.4 years
September 26, 2015
September 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight loss (kg)
8 weeks
Secondary Outcomes (2)
Lipid profile
8 weeks
Insulin resistance
8 weeks
Study Arms (2)
PACER diet
EXPERIMENTALHigh Protein Atkin's Complete (Lacto) VEgetaRian Diet (PACER Diet) to be followed for 8 weeks.
Standard weight reducing diet
ACTIVE COMPARATORThis group was prescribed Standard weight reducing diet to be followed for 8 weeks.
Interventions
Standard weight reducing diet to be followed for 8 weeks
Eligibility Criteria
You may qualify if:
- Age 25 to 60 years
- Body mass index (BMI) ≥ 25 kg/m2 to 40 kg/m2
- Subjects who have stable weight, i.e. who have not had more than ± 3 kg variation in their weight level in the 3 months prior to screening for this study.
- Absence of significant disease or clinically significant medical history or physical examination during screening in the view of the investigator.
- Subjects willing to provide written inform consent to participate in the study.
You may not qualify if:
- Body mass index (BMI) \> 40 kg/m2
- Any patient taking/requiring drugs known to effect insulin resistance, lipids, vascular reactivity, during the intervention period would be excluded from the study
- Patients on any drugs that change the weight or in conditions where dietary protein supplementation is contraindicated
- Subjects who are consuming a high protein diet on randomization, to be excluded
- Acute infections or chronic debilitating diseases like tuberculosis, malignancy, HIV infection etc
- Any life threatening serious disorder of the liver, kidneys, heart, lungs or other organs
- Pregnancy \& lactation
- Patients having diagnosed with any of the following:
- Type 2 diabetes mellitus
- Cushing's disease
- Severe end organ damage
- Unwillingness to give written informed consent for participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fortis Flt Lt Rajan Dhall Hospital
New Delhi, National Capital Territory of Delhi, 110070, India
Related Publications (2)
Bhardwaj S, Misra A. Obesity, diabetes and the Asian phenotype. World Rev Nutr Diet. 2015;111:116-22. doi: 10.1159/000362308. Epub 2014 Nov 17. No abstract available.
PMID: 25418400BACKGROUNDJenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, Faulkner DA, Vidgen E, Greaves KA, Paul G, Singer W. The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med. 2009 Jun 8;169(11):1046-54. doi: 10.1001/archinternmed.2009.115.
PMID: 19506174BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anoop Misra, MD
Diabetes Foundation, India
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Anoop Misra
Study Record Dates
First Submitted
September 26, 2015
First Posted
September 29, 2015
Study Start
January 1, 2012
Primary Completion
June 1, 2014
Study Completion
November 1, 2014
Last Updated
September 29, 2015
Record last verified: 2015-09